Precision antimicrobial therapeutics: the path of least resistance?
Ontology highlight
ABSTRACT: The emergence of drug-resistant pathogens has led to a decline in the efficacy of traditional antimicrobial therapy. The rise in resistance has been driven by widespread use, and in some cases misuse, of antibacterial agents in treating a variety of infections. A growing body of research has begun to elucidate the harmful effects of broad-spectrum antibiotic therapy on the beneficial host microbiota. To combat these threats, increasing effort is being directed toward the development of precision antimicrobial therapeutics that target key virulence determinants of specific pathogens while leaving the remainder of the host microbiota undisturbed. This includes the recent development of small molecules termed "mannosides" that specifically target uropathogenic E. coli (UPEC). Mannoside
SUBMITTER: Spaulding CN
PROVIDER: S-EPMC5829159 | biostudies-literature | 2018
REPOSITORIES: biostudies-literature
ACCESS DATA